ClinicalTrials.govpublic full text
Medico-economic Evaluation Comparing the Impact of the New Fixed-dose Nivolumab Regimen With the Old mg/kg Regimen in the Management of Patients With Metastatic Cancer
metastatic cancer, nivolumab, lung, kidney cancer, melanoma, cost-effectiveness, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1010972
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.